Results 171 to 180 of about 1,716,661 (233)

Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease. [PDF]

Proc Natl Acad Sci U S A
Boskovic P, Shalita R, Gao W, Vernon H, Deng YL, Colonna M, Majzner RG, Amit I, Kipnis J.   +8 more
europepmc   +1 more source

Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas. [PDF]

Front Immunol
Pandey T, Samat D, Dahiya S, Patel SA.
europepmc   +1 more source

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells. [PDF]

Bone Marrow Transplant
Krauß SM, Weibl K, Bach E, Brückner M, Weigert A, Tumewu T, Ruschpler E, Vogtmann G, Hoffmann S, Penack O, Janz M, Buhmann R, Henschler R, Bullinger L, Keller U, Schwind S, Merz M, Jentzsch M, Franke GN, Herling M, Platzbecker U, Metzeler KH, Vučinić V.   +22 more
europepmc   +1 more source

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study. [PDF]

Open Forum Infect Dis
Huggins J, Messina JA, Saullo J, Xie J, Zhang A, Paranjpe I, Lu R, Walsh M, Mohnasky M, Stromberg J, Cao F, Grover N, Saha M, Darwin A, Torres N, Tam P, Schrum D, Eberwein E, Kennedy E, Kelsey CR, Choi T, McKinney M, Kang Y, Smith M, Andermann TM.   +24 more
europepmc   +1 more source

Chimeric Antigen Receptor T-Cells in Myasthenia Gravis: Advances, Safety Challenges, and Future Directions. [PDF]

Muscle Nerve
Hegelmaier T, Duscha A, Desel C, Stassen S, Krzemien T, Hennemann AK, Pappa V, Haghikia A.   +7 more
europepmc   +1 more source

Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer. [PDF]

J Clin Oncol
Qi C, Liu C, Gong J, Wang X, Wang Z, Xu T, Liu D, Zhang P, Li J, Zhang M, Zhang X, Lu M, Zhou J, Lu Z, Peng Z, Cao Y, Yuan J, Wang Y, Lu X, He T, Ding Y, Wu F, Liu D, Li J, Shen L.   +24 more
europepmc   +1 more source

Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases. [PDF]

Research (Wash D C)
Shao Q, Chen D, Shao W, Ye Q.
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy for rheumatic diseases: from B-cell depletion to immune reset and beyond. [PDF]

Front Immunol
Zhan Y, Hu C, Xiao K.
europepmc   +1 more source

Chimeric antigen receptor (CAR)-T cell therapy for solid tumors in pediatric patients: current breakthroughs, dilemmas, and strategies. [PDF]

Exp Hematol Oncol
Mai Y, Wang Z, Wang J, Song M, Xiang T, He Y, Chang AH, Zhang Y.   +7 more
europepmc   +1 more source

Application and challenges of chimeric antigen receptor T cell therapy in the treatment of acute myeloid leukemia (Review). [PDF]

Oncol Lett
Zhang J, Wang F, Sui D, Huang Z, Chen Y.
europepmc   +1 more source